Syneos Health, Inc.

Syneos Health, Inc. is a leading global biopharmaceutical solutions organization that provides a comprehensive range of services to support the development and commercialization of innovative therapies.

With a commitment to accelerating customer success, Syneos Health integrates clinical and commercial capabilities to deliver a seamless experience for clients in the healthcare sector.

The company operates through two primary segments: Clinical Solutions and Commercial Solutions, ensuring that they meet the diverse needs of their clients throughout the product lifecycle.

• Clinical Solutions: This segment focuses on providing clinical development services, including Phase I-IV clinical trials, regulatory consulting, and data analytics.
• Commercial Solutions: This segment offers a wide array of services such as market access, commercialisation strategies, and patient engagement initiatives.

Syneos Health prides itself on its innovative approach, leveraging advanced technology and data-driven insights to enhance decision-making and improve outcomes.

Headquartered in the UK, the company has a global presence, with operations in over 110 countries, allowing them to effectively support clients worldwide.

Syneos Health is dedicated to fostering partnerships with biopharmaceutical companies, helping them navigate the complexities of drug development and market entry.

Through its commitment to excellence and a patient-centric focus, Syneos Health aims to transform the way therapies are developed and delivered, ultimately improving patient lives.

As a trusted partner in the healthcare industry, Syneos Health continues to evolve, adapting to the changing landscape and meeting the needs of its clients with agility and expertise.